These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20978914)

  • 21. Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity.
    Li J; Goto M; Yang X; Morris-Natschke SL; Huang L; Chen CH; Lee KH
    Bioorg Med Chem Lett; 2016 Jan; 26(1):68-71. PubMed ID: 26598461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
    Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
    Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564.
    Holz-Smith SL; Sun IC; Jin L; Matthews TJ; Lee KH; Chen CH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):60-6. PubMed ID: 11120945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in the study of structural modifications and biological activities of betulinic acids].
    Lan P; Zhang DM; Chen WM; Ye WC
    Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.
    Sun IC; Chen CH; Kashiwada Y; Wu JH; Wang HK; Lee KH
    J Med Chem; 2002 Sep; 45(19):4271-5. PubMed ID: 12213068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry.
    Soler F; Poujade C; Evers M; Carry JC; Hénin Y; Bousseau A; Huet T; Pauwels R; De Clercq E; Mayaux JF; Le Pecq JB; Dereu N
    J Med Chem; 1996 Mar; 39(5):1069-83. PubMed ID: 8676342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants.
    Dang Z; Qian K; Ho P; Zhu L; Lee KH; Huang L; Chen CH
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5190-4. PubMed ID: 22818973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives.
    Huang L; Ho P; Lee KH; Chen CH
    Bioorg Med Chem; 2006 Apr; 14(7):2279-89. PubMed ID: 16314103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.
    Mao Y; Li Y; Hao M; Zhang S; Ai C
    J Mol Model; 2012 May; 18(5):2185-98. PubMed ID: 21947448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.
    Patel PK; Bhatt HG
    Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Betulinic acid derivatives as HIV-1 antivirals.
    Aiken C; Chen CH
    Trends Mol Med; 2005 Jan; 11(1):31-6. PubMed ID: 15649820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives.
    Hashimoto F; Kashiwada Y; Cosentino LM; Chen CH; Garrett PE; Lee KH
    Bioorg Med Chem; 1997 Dec; 5(12):2133-43. PubMed ID: 9459011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.
    Cichewicz RH; Kouzi SA
    Med Res Rev; 2004 Jan; 24(1):90-114. PubMed ID: 14595673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peltophorum africanum, a traditional South African medicinal plant, contains an anti HIV-1 constituent, betulinic acid.
    Theo A; Masebe T; Suzuki Y; Kikuchi H; Wada S; Obi CL; Bessong PO; Usuzawa M; Oshima Y; Hattori T
    Tohoku J Exp Med; 2009 Feb; 217(2):93-9. PubMed ID: 19212101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents.
    Kashiwada Y; Hashimoto F; Cosentino LM; Chen CH; Garrett PE; Lee KH
    J Med Chem; 1996 Mar; 39(5):1016-7. PubMed ID: 8676334
    [No Abstract]   [Full Text] [Related]  

  • 37. Betulinic acid and its derivatives: a review on their biological properties.
    Yogeeswari P; Sriram D
    Curr Med Chem; 2005; 12(6):657-66. PubMed ID: 15790304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conjugates of betulin derivatives with AZT as potent anti-HIV agents.
    Xiong J; Kashiwada Y; Chen CH; Qian K; Morris-Natschke SL; Lee KH; Takaishi Y
    Bioorg Med Chem; 2010 Sep; 18(17):6451-69. PubMed ID: 20673723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Cichero E; Fossa P
    J Mol Model; 2012 Apr; 18(4):1573-82. PubMed ID: 21805124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action.
    Evers M; Poujade C; Soler F; Ribeill Y; James C; Lelièvre Y; Gueguen JC; Reisdorf D; Morize I; Pauwels R; De Clercq E; Hénin Y; Bousseau A; Mayaux JF; Le Pecq JB; Dereu N
    J Med Chem; 1996 Mar; 39(5):1056-68. PubMed ID: 8676341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.